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The a-mannosyltransferase AceA from Acetobacter xy-
linum belongs to the CaZY family 4 of retaining glyco-
syltransferases. We have identified a series of either
highly conserved or invariant residues that are found in
all family 4 enzymes as well as other retaining glycosyl-
transferases. These residues included Glu-287 and Glu-
295, which comprise an EX7E motif and have been pro-
posed to be involved in catalysis. Alanine replacements
of each conserved residue were constructed by site-di-
rected mutagenesis. The mannosyltransferase activity
of each mutant was examined by both an in vitro trans-
ferase assay using recombinant mutant AceA expressed
in Escherichia coli and by an in vivo rescue assay by
expressing the mutant AceA in a Xanthomonas campes-
tris gumH2 strain. We found that only mutants K211A
and E287A lost all detectable activity both in vitro and in
vivo, whereas E295A retained residual activity in the
more sensitive in vivo assay. H127A and S162A each
retained reduced but significant activities both in vitro
and in vivo. Secondary structure predictions of AceA
and subsequent comparison with the crystal structures
of the T4 b-glucosyltransferase and MurG suggest that
AceA Lys-211 and Glu-295 are involved in nucleotide
sugar donor binding, leaving Glu-287 of the EX7E as a
potential catalytic residue.
Bacterial polysaccharides assembled from polyprenol pyro-
phosphate-linked repeat units form a large group of polysac-
charides possessing an extreme structural diversity. The re-
peat unit is the structural and biosynthetic building block and
is present in many important cell surface-related polysacchar-
ides such as the O-antigen portion of lipopolysaccharides and
capsular polysaccharides, as well as in exopolysaccharides (1).
A large number of genes thought to encode glycosyltransferases
involved in the assembly of repeat units have been identified,
reflecting the extreme structural diversity of these bacterial
polysaccharides. AceA is a non-processive a-1,3 mannosyl-
transferase from Acetobacter xylinum, which transfers man-
nose from GDP-mannose (GDP-Man)1 to polyprenyl-pyrophos-
phate-linked cellobiose (Glc2-PP-Lip) during the assembly of
the heptasaccharide repeat unit of the exopolysaccharide ac-
etan (2, 3). Acetan is structurally related to the widely used
exopolysaccharide xanthan gum from Xanthomonas campestris
(see Fig. 1). AceA is homologous to the X. campestris a-1,3
mannosyltransferase GumH, which catalyzes the analogous
reaction in the biosynthesis of the repeat unit of xanthan gum.
Indeed, the aceA gene was cloned by functional complementa-
tion of a X. campestris gumH mutant strain (2). AceA and
GumH are both retaining glycosyltransferases as they catalyze
the formation of a glycosidic linkage with retention of stereo-
chemistry about the donor sugar anomeric carbon. It was first
reported that AceA and GumH belong to a relatively small
family of mostly prokaryotic a-mannosyltransferases. This
family includes the eukaryotic N-acetylglucosaminyltrans-
ferase PigA, as well as the mannosyltransferases WbdA, WbdB,
and WbdC (3), which are required for the assembly of the
Escherichia coli 09 serotype lipopolysaccharide O-antigen.
Moreover, a number of the amino acids, His-127, Ser-162, Lys-
211, Leu-270, Glu-287, and Glu-295, were found to be highly
conserved in this family and proposed to play a functional role
(4).
More recent and more wide reaching glycosyltransferase
classification schemes have placed AceA in larger families
again comprising mostly retaining glycosyltransferases. For
example, AceA is found in family 4 of Campbell’s scheme
(CaZY) (5, 6), in glycosyltransferase 1 family (GT1F) of the
Pfam data base (7), and in family NRD1 defined by Kapitonov
and Yu (8). CaZY family 4 comprises more than 300 proteins.
Pfam GT1F embodies 397 proteins, including all glycosyltrans-
ferases of CaZY family 4 and a limited number of glycosyltrans-
ferases from families 3 and 5. GT1F enzymes share a 150-
amino acid domain called the GT1 domain (GT1D). In AceA,
this domain is found toward the COOH terminus and corre-
sponds to the region in which we had previously identified the
highly conserved residues Lys-211, Leu-270, Glu-287, and Glu-
295 (Fig. 2). Three of these residues (excluding Leu-270) are in
fact strictly conserved among all members of CaZY family 4.
The two Glu residues, 287 and 295, correspond to the EX7E
motif. This motif is also found in other important retaining
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glycosyltransferases such as yeast and mammalian glycogen
synthases, which belong to CaZY family 3 but not to Pfam
GT1F. It has been suggested that the Glu residues of the EX7E
motif may be the catalytic residues of a proposed double dis-
placement mechanism for glycosyltransferases that function
with retention of the anomeric configuration (4, 8). However, to
date there are little biochemical and no structural data of
EX7E-containing glycosyltransferases to support this
hypothesis.
Using recombinant AceA expressed in E. coli, we have re-
cently shown that AceA behaves as a soluble protein and is
capable of transferring mannose from GDP-Man to Glc2-PP-Lip
with formation of an a linkage in vitro (3). Here we have
extended our studies by using site-directed mutagenesis to
create a series of AceA mutants in which each of the highly
conserved amino acids identified were replaced by alanine. The
functional importance of each mutant was subsequently deter-
mined both in vivo, by complementation of XcH mutant strain,
and in vitro with the recombinant form of AceA expressed in E.
coli. We have found that only mutations at positions Lys-211
and Glu-287, the first Glu of the EX7E motif, completely inac-
tivated the enzyme both in vitro and in vivo. Mutation of
Glu-295, the second Glu of the EX7E motif, resulted in an
enzyme with very low, but reproducible residual activity in
vivo. Comparison of the primary sequence of AceA with the
recent crystal structure of the N-acetylglucosaminyltrans-
ferase MurG suggests that Lys-211 and Glu-295 may be in-
volved in nucleotide sugar binding, leaving Glu-287 as a poten-
tial catalytic residue. Finally, while assessing the integrity of
the recombinant form of AceA in X. campestris, we have also
found that AceA is associated with the membrane fraction,
suggesting that AceA is recruited by a membrane receptor.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions—The X. campestris strains used
were FC2 (a derivative of the wild type strain NRRL B-1459) and two
mutants defective in xanthan production: XcH (FC2 carrying plasmid
pGum52–18S integrated into the a-mannosyltransferase coding se-
quence (Ref. 9)) and Xc1231 (a X. campestris strain carrying a complete
deletion of the gum region (Ref. 10)). These strains were grown in YM
(11) or in minimal medium (12) at 28 °C. The E. coli strains used were
JM109, S17–1 (13), XL1-Blue, and BL21 (DE3) (Novagen). They were
all grown in Luria-Bertani medium at 37 °C, except BL21 (DE3) that
was grown in TB medium (14) for the preparation of recombinant
enzyme. Antibiotics were supplemented as required at the following
concentrations: tetracycline, 12.5 mg/ml; kanamycin, 50 mg/ml; and
ampicillin, 100 mg/ml.
General Procedures—Protein determinations were done by the
method of Lowry, except in membrane preparations, in which a modi-
fication of the method was used (15). Quantification of partially purified
AceA was done by densitometry of Coomassie Blue-stained gels using
Gelworks 1D Analysis software (NonLinear Dynamics Ltd.). SDS-
PAGE, Western blot, cloning, and transformation procedures were done
according to established protocols.
Bioinformatic Methods—The secondary structure predictions were
created by the Jpred2 server (available on the World Wide Web) using
AceA as seed (16). We have chosen this method because it uses multiple
sequence alignments obtained by BLAST, after removal of redundant
sequences. The classification of glycosyltransferases by Campbell et al.
(5, 6) is accessible at the CaZY data base on the World Wide Web.
Threading studies were performed using Procyon (17). Pfam GT1F can
be accessed at the Sanger protein families (Pfam) data base on the
World Wide Web.
Molecular Biology and Genetic Procedures—Site directed mutants
were obtained using the USE mutagenesis kit and the Toggle selection
primer SspI/StuI (Amersham Pharmacia Biotech) on pDGC2 (3), using
appropriate mutagenic primers. The fidelity of the mutation reaction
was confirmed by single strand sequencing of the complete open reading
frame. The cloning of wild type and mutant forms of aceA into the
expression vector pET29a was done as described previously (3). Positive
clones were identified by restriction analysis and termed pCrGC2 s.
Subsequently, they were introduced into BL21 (DE3). pBBR-AceA and
the corresponding mutants were constructed by cloning a 1,259-base
pair fragment comprising the aceA gene from pDGC2, into the KpnI/
PstI site of the broad host range vector pBBR1 MCS3 (tetR). The ligation
products were used to transform E. coli JM109. Clones harboring the
desired construct were confirmed by KpnI/PstI digestion of plasmid
DNA. The plasmids were then introduced into E. coli S17–1 and trans-
ferred to X. campestris by biparental conjugation.
Overexpression of Wild Type and Mutant AceA S-tag—The cloning of
the AceA open reading frame into the plasmid pET29 to obtain pCrGC2
was done as described previously (3). The S-tag peptide was fused to the
NH2-terminal end of the AceA protein. E. coli BL21 (DE3)/pCrGC2 cells
were grown as indicated above. When the cultures reached an A600
value of 0.8, protein expression was induced by adding IPTG at a final
concentration of 1 mM. After 2 h, cells were harvested by centrifugation
and washed with 70 mM Tris-HCl, pH 8.0. Aliquots of induced and
uninduced samples were resuspended in denaturing buffer and submit-
ted to SDS-PAGE. Proteins were detected by Coomassie Blue staining.
The fusion AceA-S-tag was confirmed by Western blot using the S-tag
Western blot kit (Novagen) according to the manufacturer’s
instructions.
Antibody Preparation—The rabbit polyclonal antiserum to the AceA
protein was obtained from renatured inclusion bodies. The inclusion
bodies were obtained by overexpression of wild type AceA in E. coli
BL21 (DE3)/pCrGC2. Cells were collected by centrifugation and dis-
rupted as described below. The total cell extracts were centrifuged at
3,000 3 g for 5 min at 4 °C to remove aggregates. The inclusion bodies
were recovered from the 3,000 3 g supernatant by centrifugation at
13,000 3 g for 15 min at 4 °C. The pellet was resuspended in 10 mM
Tris-HCl, pH 7.5, and washed twice with the same buffer supplemented
with 2 M urea and 0.5% Triton X-100. The washed inclusion bodies were
resuspended in 50 mM Tris-HCl, pH 7.5, 8 M urea, and agitated at 4 °C
during 24 h for solubilization. Afterward they were centrifuged at
12,000 3 g for 10 min at 4 °C. The supernatant was diluted to 0.3 M
urea. Urea was removed by ultrafiltration through an Amicon PM 10
membrane. The remaining protein was lyophilized and used to immu-
nize rabbits (18). For the purification of the antiserum, an affinity resin
was obtained by linking an induced extract of BL21 (DE3)/pET29a to
CNBr-activated Sepharose 4B (Amersham Pharmacia Biotech). The
binding reaction was performed in the batch mode at 4 °C in a shaker
at 30 rpm overnight. The obtained supernatant was enriched in anti-
bodies specific to AceA.
Subcellular Fractionation and Protein Purification—Fractionation of
E. coli or X. campestris cultures was performed as follows. Cells were
FIG. 1. Structure of the repeat unit
of xanthan and acetan.
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grown as described above and collected by centrifugation. After washing
with 70 mM Tris-HCl, 10 mM EDTA, pH 8.0, they were resuspended in
an appropriate volume of the same buffer and disrupted by three
passages through a French pressure cell (18,000 p.s.i.). The cell extract
was successively centrifuged at 2,000 3 g, 15,000 3 g, and finally at
100,000 3 g during 1 h. Aliquots of each fraction were then analyzed by
SDS-PAGE and/or Western blot. Partial purification of AceA was ac-
complished from the 100,000 3 g supernatants of E. coli BL21 (DE3)/
pCrGC2, using the S-tag thrombin purification kit (Novagen). AceA was
eluted with biotinylated thrombin according to the manufacturer’s in-
structions. Thrombin was subsequently removed with streptavidin-
agarose (Novagen). AceA represented 40–60% of total protein in the
purified fraction, as judged by densitometry of Coomassie Blue-stained
gels.
In Vitro Activity of Recombinant AceA—The in vitro activity assays
were carried out as described previously (3). The acceptor (Glc2-PP-Lip)
was freshly prepared using X. campestris permeabilized cells. The ac-
ceptor was immediately used in the mannosyltransferase assays. The
reaction mix contained: 0.4 mg of AceA, 1% Triton X-100, 6 mM MgCl2,
15 ml of cold acceptor, and 0.25 mCi of GDP-[14C]Man in a final volume
of 100 ml. After incubation at 37 °C for 8 min, the reaction was stopped
by addition of 200 ml of chloroform:methanol (1:1). Glycolipids were
isolated from the organic phase and the protein pellet. Oligosaccharides
were released by mild acid hydrolysis and treated with alkaline phos-
phatase as described (3). Aliquots of the remaining aqueous phase were
counted in a liquid scintillation counter, and the rest of the samples
concentrated and submitted to TLC.
Assay of Mannose Incorporation in Permeabilized XcH—XcH cells
expressing the different forms of AceA were permeabilized by EDTA
treatment as described previously (19). The reaction mixtures con-
tained: 70 mM Tris-HCl, pH 8.2, 8 mM MgCl2, permeabilized cells
(0.6–0.8 mg of protein), 4 mM UDP-glucose, and 0.25 mCi of GDP-
[14C]Man (277 mCi/mmol) in a final volume of 70 ml. Reactions were
carried out at 20 °C for 30 min and stopped by adding 200 ml of 70 mM
Tris-HCl, 10 mM EDTA buffer, pH 8.2. The reaction mixtures were
centrifuged and the cells washed with the same buffer. Glycolipids were
obtained from the cell pellet by extraction with chloroform:methanol:
water (1:2:0.3). Oligosaccharides were obtained and processed as de-
scribed above.
Quantification of Secreted Polysaccharides—Cultures of XcH harbor-
ing either the wild type or a mutant aceA gene were grown in minimal
medium (12) during 48 h. Cells were separated by centrifugation, and
500-ml aliquots of the supernatants were added with two volumes of
ethanol. The precipitated xanthan was resuspended in water, and
quantification was done by the meta-hydroxybiphenyl method (20).
Spectroscopic Studies of Secreted Polysaccharides—The relevant X.
campestris strains were cultured in minimal medium (12) for 48 h. Cells
from 1-liter cultures were removed by centrifugation at 3,000 3 g.
Polymers were precipitated by adding two volumes of ethanol and 1 M
NaCl to the culture supernatants. The precipitates were recovered by
centrifugation, and subsequently washed with ethanol at 70%, 75%,
80%, 85%, 90%, and 95%. The samples were resuspended in water and
sonicated to reduce viscosity. Finally they were lyophilized and resus-
pended in D2O. The
1H NMR spectra were recorded with a Brucker
300-MHz spectrometer and referenced to residual H2O.
RESULTS
Secondary Structure Prediction and Location of the Con-
served Amino Acids—AceA residues His-127, Ser-162, Lys-211,
Leu-270, Glu-287, and Glu-295 were initially identified as con-
served residues as a result of sequence comparison studies
performed on a group of glycosyltransferases, which comprises
mostly retaining mannosyltransferases (4). Three of these res-
idues, Lys-211, Glu-287, and Glu-295, are strictly conserved
within all members of CaZY family 4, which comprises retain-
ing glycosyltransferase with a wide variety of donor and accep-
tor specificities. In order to gain insight as to how these con-
served residues may be situated with respect to the structure of
AceA, we performed secondary structure predictions using the
Jpred2 server and AceA as seed (see “Experimental Proce-
dures”). The strength of this method is that the prediction is
made using proteins similar to the seed (AceA). As shown in
Fig. 2, AceA and other proteins that belong to the GT1F are
predicted to consist of alternating a-helixes and b-sheets (data
not shown). This prediction is compatible with a variant of the
Rossman fold. A common structural feature of the few available
crystal structures of glycosyltransferases resolved to date is the
presence of variants of the Rossman fold. This a/b fold consists
of an a-b-a sandwich and is involved in the binding of the
nucleotide moiety of the nucleotide-diphosphosugar (21–25). In
the case of AceA, each of the conserved residues except Glu-295
are found in regions of the protein predicted to be close to the
beginning of a-helices or the ends of b-sheets, which is consist-
ent with the idea that these residues may play some functional
role.
To search for further ideas about the structure of AceA, and
the putative function of conserved amino acids, we have per-
formed threading studies using AceA and other family 4 pro-
tein sequences as seed. The best and most significant scores
were obtained with the structure of the E. coli N-acetylglu-
cosaminyltranferase MurG and T4bGlcT. MurG transfers Glc-
NAc from UDP-GlcNAc to undecaprenol pyrophosphate-linked
FIG. 2. Secondary structure align-
ment of AceA, T4bGlcT, and MurG.
Secondary structure of T4bGlcT was ob-
tained from the PDB entry 1C3J and
MurG from the entry 1F0K. The predic-
tion of the secondary structure of AceA
was obtained as described under “Exper-
imental Procedures.” This alignment was
also derived from an alignment of the
HCA plots (available upon request). The
gray barrels correspond to a-helices and
the dark arrow b-sheets. Gray horizontal
lines indicate the regions of similar sec-
ondary structure (also joined by vertical
lines). The GT1D is indicated by a gray
box in AceA. Location of mutated amino
acids in AceA, and the equivalent amino
acid or regions in T4bGlcT and MurG are
shown by a vertical arrow. The thick black
box indicates that this domain is mostly
involved in the binding of the nucleotide
sugar in both MurG and T4bGlcT.
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MurNac during the biosynthesis of the peptidoglycan building
block, while T4bGlcT glucosylates DNA at 5-hydroxymethylcy-
tosine residues. Both of these enzymes act with inversion of the
configuration of the reaction center. MurG belongs to CaZY
family 28, which is thought to be related to families 3, 4, and 5.
T4bGlcT remains unclassified. Secondary structure predictions
of AceA and the three-dimensional structures of MurG and
T4bGlcT, as well as a comparative HCA analysis, led to a
secondary structure alignment of these three glycosyltrans-
ferases (see Fig. 2). Although neither MurG nor T4bGlcT pos-
sess an EX7E motif, both possess a Glu residue in the middle of
an a-helix at the equivalent position as AceA Glu-295. In both
the T4bGlcT and MurG crystal structures, the glutamate side
chain makes a direct hydrogen bond to the ribose-OH group of
the nucleotide sugar donor (21, 22, 25). In the structure of
T4bGlcT bound to UDP, Arg-191 interacts with the a-phos-
phate of UDP (21, 22). Secondary structure alignments based
on the threading results suggested that the conserved residue
Lys-211 of AceA is in the same position as Arg-191 of T4bGlcT.
Similarly, the model of MurG bound to UDP-GlcNAc predicts
contacts between the a-phosphate of the nucleotide sugar donor
and of the G3 loop (25), which is located in the same position as
the loop of AceA containing Lys-211. Finally, the model of
UDP-Glc bound to the nucleotide binding site of T4bGlcT re-
vealed that Asp-100 of T4bGlcT is in the best position to act as
catalytic amino acid (22). Secondary structure alignments,
based on the threading results, suggested that nonconserved
Asp-109 of AceA is in the same position as Asp-100 of T4bGlcT.
With these clues in mind, we have created a series of site-
directed mutants of each of the residues of interest within
AceA, i.e. Asp-109, His-127, Ser-162, Lys-211, Leu-270, Glu-
287, and Glu-295, in which each targeted residue was replaced
by Ala.
Characterization of Mutant Forms of AceA Expressed in E.
coli—In order to carry out biochemical studies to elucidate the
function of conserved amino acids, it was necessary to overex-
press wild type and mutant forms of AceA in E. coli. The site
directed mutants were expressed as described under “Experi-
mental Procedures.” Total cell extracts obtained before and
after induction with IPTG were submitted to SDS-PAGE. A
major band of about 46 kDa, corresponding to AceA, appeared
upon induction with IPTG (data not shown). It was previously
reported that AceA behaves as a soluble protein when ex-
pressed in E. coli (3). None of the mutations affects the local-
ization of AceA in E. coli, since all of them are found in the
cytosol (data not shown). The expression levels of the different
forms of AceA in the 100,000 3 g supernatants differ consid-
erably, probably due to differences in stability (Fig. 3).
Wild type and mutant forms of AceA were purified from the
100,000 3 g supernatants by affinity chromatography using
S-protein agarose to bind the S-tag fusion epitope. The purified
fraction contained AceA and a 66-kDa protein. Amino-terminal
microsequencing revealed that the 66-kDa protein corresponds
to the E. coli chaperone GroEL (data not shown). For the in vivo
activity assay, the different forms of AceA were quantified by
densitometry of a Coomassie Blue-stained acrylamide gel.
To evaluate the effect of amino acid replacement on enzy-
matic activity, we have determined the ability of the different
forms of AceA to transfer [14C]Man from GDP-[14C]Man to the
native Glc2-PP-Lip acceptor isolated from X. campestris as
described previously (3). Since the Glc2-PP-Lip can only be
isolated in minute quantities, it was not possible to assess
either its purity or precise concentration. To overcome these
limitations, we have used the same stock of freshly prepared
acceptor for each series of experiments, allowing us to deter-
mine the Vi of the wild type and mutant proteins for a given
concentration of substrate (Fig. 4). Replacement of Asp-109,
His-127, or Ser-162 by Ala resulted in a strong decrease of Vi
(97–98% of wild type AceA). By contrast, Ala replacement of
either of the highly conserved amino acids present in GT1D
(Lys-211, Glu-287, and Glu-295) led to complete inactivation of
the protein as judged by this assay. The mutant AceA-L270A
retained 40% of AceA activity. Release of the radioactive oligo-
saccharides from the lipid anchor and TLC analysis confirmed
that AceA, and its enzymatically active variants D109A,
H127A, S162A, and L270A (data not shown) produced the
expected trisaccharide.
Effect of the Substitution of Conserved Amino Acids in AceA
on the Complementation of the XcH Strain—To further assess
the importance of the conserved amino acids to AceA activity,
the wild type and mutant forms of the enzyme were introduced
into the XcH mutant strain that does not produce xanthan gum
(gum2 phenotype) as a result of an insertion in the GumH
coding sequence (9). Quantification of the xanthan accumu-
lated by the XcH strain expressing AceA mutant forms pro-
vides a powerful means to detect minor levels of AceA activity
that may not be detected by the in vitro assay. Differences in
colony morphologies were observed among the transconjugants
(data not shown). The mucoid phenotype, a distinctive feature
of gum1 strains, was partially restored in XcH complemented
with wild type AceA as well as D109A, H127A, S162A, and
L270A, while complementation with K211A, E287A, and
E295A resulted in a non-mucoid phenotype. Xanthan produced
by each of the complemented strains was isolated and quanti-
fied as described under “Experimental Procedures” (Fig. 5).
Since the quantity of xanthan produced by X. campestris XcH
(gumH2) complemented with wild type AceA was 60% less than
that normally produced by the wild type strain X. campestris
FC2, the amount of xanthan produced in the site-directed mu-
tants was compared with that of XcH complemented with AceA
FIG. 3. Subcellular localization of
AceA in E. coli BL21 (DE3). Production
of recombinant proteins and fractionation
of cell extracts were carried out as de-
scribed in “Experimental Procedures.”
100,000 3 g supernatants containing 15
mg of total proteins were submitted to
10% SDS-PAGE and then transferred to a
polyvinylidene difluoride membrane. The
different forms of the AceA-S-tag fusion
proteins were detected with the S-protein
alkaline phosphatase conjugate.
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(100%). XcH AceA-L270 accumulated 70% as much xanthan as
XcH AceA did. Surprisingly, the XcH strains expressing the
mutants that are marginally active in vitro, D109A, H127A,
and S162A accumulated between 20 and 40% of AceA in vivo.
The levels of polysaccharide in the XcH strains harboring
K211A and E287A were not distinguishable from the non-
complemented XcH, indicating again that these two amino
acids are strictly essential for biochemical activity. Interest-
ingly, the XcH strain expressing AceA-E295A produced a low,
but detectable level of EPS (4%). These results also show that
XcH AceA-K211A and -E287A are completely incapable of re-
storing EPS synthesis.
To confirm that the EPS produced by XcH strains expressing
mutant forms of AceA is actually xanthan, we have purified the
polysaccharides and submitted them to structural analysis.
Since E295A produced very little amounts of polysaccharide,
we have used the strain XcH E295G that produces slightly
more EPS than XcH E295A.2 The EPSs produced by strains
D109A, H127A, S162A, L270A, and E295G were viscous, indi-
cating the presence of a high molecular weight polysaccharide.
The 1H NMR spectra of D109A, H127A, S162A, and L270A
display the characteristic signals of xanthan gum, in particular
at d 1.8, 2.1, and 5.2, which correspond to the acetyl, ketal
pyruvate and a(1–3)-Man moieties (Fig. 6). The same peaks
were also found in the 1H NMR spectrum of the EPS isolated
from E295G, however, other peaks are also present and they
may correspond to yet uncharacterized polysaccharides.3 We
have concluded then that D109A, H127A, S162A, L270A, and
E295A produce xanthan gum. On the other hand, the ethanol-
insoluble material from XcH strains expressing either K211A
or E287A did not show a viscous appearance and was of insuf-
ficient quantity for NMR analysis.
[14C]Mannose Incorporation in the XcH Strains Expressing
Wild Type and Mutant AceA Forms—Since it is possible that
AceA mutant forms K211A and E287A block the production of
xanthan due to uncontrolled transfer to other substrates, we
have analyzed the lipid-linked oligosaccharides in the different
complemented XcH strains. Permeabilized XcH cells comple-
mented with the different forms of AceA, were incubated in
presence of GDP-[14C]Man. The glycolipid fraction was iso-
lated, and oligosaccharides were released and analyzed by TLC
(see “Experimental Procedures”). Although the rapid transfor-
mation of Man-Glc2-PP-Lip into the higher intermediates of
xanthan gum biosynthesis prevented its accurate quantifica-
tion, we found that the trisaccharide [14C]Man-Glc2 was pro-
duced by all the strains except XcH AceA-K211A and XcH
AceA-E287A (data not shown). These two strains did not pro-
duce any other labeled oligosaccharide. These results indicate
that the failure of the XcH AceA-K211A and E287A to produce
xanthan gum is due to inactivation of AceA.
Subcellular Localization of AceA in the XcH Strain—Since
either the lack and/or reduction of activity could be due to low
levels of the recombinant AceA protein when expressed in XcH,
we have inmunolocalized AceA in Western blots of total ex-
tracts from the different XcH strains as described under “Ex-
perimental Procedures.” AceA was found to be present in these
extracts (data not shown). Nevertheless, lack of activity may be
due to a different subcellular location of the mutant AceA
forms. We then performed a subcellular fractionation of total
extracts, and localized AceA by Western blot. Although in E.
coli AceA is present in the soluble fraction, unexpectedly in the
XcH strains, AceA was found to be associated with the mem-
brane fraction. As shown in Fig. 7, all the mutant forms of AceA
were also present in the membrane fraction and are expressed
at least at the level of wild-type AceA. In all cases more than
90% of AceA was found associated to the membrane fraction. It
has been suggested that polysaccharide biosynthesis enzymes
are organized in a multiprotein complex associated with mem-
branes (1, 26). Knowing that AceA is expressed as a soluble
protein in E. coli, we reasoned that another Gum protein may
recruit AceA to the membrane. To test this hypothesis, we
introduced AceA into X. campestris Xc1231, a strain lacking the
gum region, and looked for the subcellular localization of AceA
2 P. L. Abdian, unpublished results.
3 A. Heyraud, unpublished results.
FIG. 4. In vitro activity of AceA-S-tag. The activities of partially
purified fusion proteins were detected as described under “Experimen-
tal Procedures.” A, relative activities of the mutant forms compared
with wild type AceA. Values are the mean of two determinations. B,
normalized amount of protein used for the in vitro assay, detected by
Western blot with the S-protein alkaline phosphatase conjugate.
FIG. 5. Xanthan production in XcH complemented strains. Xan-
than produced by XcH strains harboring different forms of AceA in 48-h
cultures was isolated and quantified as described under “Experimental
Procedures.” A, relative amounts of xanthan produced by the mutant
forms compared with wild type AceA. The percentages shown are the
mean values of three independent determinations. B, normalization of
protein quantities shown by Western blot with the polyclonal antiserum
raised against AceA. D109 and H127 stands for D109A and H127A,
respectively.
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by Western blot. In most of the experiments, AceA was not
detected in total extracts, preventing cell fractionation experi-
ments. However, in one single experiment, we found that AceA
was expressed in small quantities and that it was associated
with the membrane fraction (data not shown). This result
shows that AceA is associated with membranes even in the
absence of other proteins of the gum region, although is per-
haps less stably expressed. This suggests that other protein
partners for AceA may exist that differ between E. coli and X.
campestris.
DISCUSSION
Here we report the results of the mutational analysis of a
number of amino acids of the a-1,3 mannosyltransferase AceA
that are highly conserved among CaZY family 4 glycosyltrans-
ferases. These residues include His-127, Ser-162, Lys-211, Glu-
287, Glu-295, and Leu-270 (4). Of these six residues, three
(Lys-211, Glu-287, and Glu-295) are strictly conserved within
the family. In addition, we have analyzed a mutant of residue
Asp-109. This residue was identified as a potential catalytic
residue after threading experiments against the known three-
dimensional structure of T4bGlcT.
The targeted amino acids can be classed into four groups on
the basis of the phenotype of the corresponding Ala substitu-
tion in AceA. First, mutation of residues Lys-211 and Glu-287
resulted in complete loss of AceA activity, as judged by both the
in vitro mannosyltransferase assay and by the in vivo comple-
mentation assay. In contrast, mutation of Glu-295 resulted in a
slightly different phenotype where AceA E295A was completely
inactive in vitro but was capable of restoring xanthan produc-
tion in the in vivo assay to a very low but reproducible level
(;4% of wt AceA). Residues Asp-109, His-127, and Ser-162
constitute a third group in which replacement of Ala resulted in
a loss of 97–98% of activity in vitro; however, these mutants
retained a significant ability to produce xanthan in the in vivo
assay (20–40%). Finally, despite the fact that the residue Leu-
270 is highly (although not strictly) conserved, AceA L270A
retained 40% of wild type activity in vitro and 71% of the
activity in vivo, strongly suggesting that this residue does not
play a critical role in the reaction mechanism. These results
confirm that the three highly conserved residues play an im-
portant role in AceA activity both in vitro and in vivo, although
only Lys-211 and the first glutamate residue of the EX7E motif,
Glu-287, are indispensable for activity.
By analogy with the well defined mechanism of retaining
glycosylhydrolases, it has been proposed that retention of the
configuration of the reaction center during glycosyltransfer
would be achieved by a double displacement mechanism involv-
ing two catalytic residues with the formation of a glycosyl-
protein intermediate (27). Acidic residues such as Glu or Asp
would be the prime candidates to act as catalytic residues. In
the case of proteins harboring the GT1 domain, it has been
proposed that the two Glu residues of the EX7E motif are the
catalytic amino acids (4, 8, 28). A role for catalysis of the first
Glu of the EX7E motif, Glu-287, is supported by our mutagen-
esis results but is neither supported nor contradicted by the
structural comparisons as neither MurG nor T4bGlcT possess
this residue. Interestingly, all known MurG proteins cloned
from different Gram-negative bacteria have a strictly con-
served Arg residue (Arg-261) in place of Glu-287. The func-
FIG. 6. 1H NMR spectra of exopolysac-
charide produced by XcH strain ex-
pressing different forms of AceA. Exopo-
lysaccharides were purified as described
under “Experimental Procedures.” The ver-
tical arrow shows the peak at d 5.2, charac-
teristic of the a(1–3)Man, P stands for pyru-
vate, A for acetate, and the asterisk shows a
peak corresponding to an uncharacterized
polysaccharide.
FIG. 7. Subcellular localization of mutant forms of AceA in
XcH complemented strains. XcH cell cultures harboring wild type or
mutant forms of AceA were disrupted and subsequently fractionated
into membrane and soluble fractions. Samples were separated by 10%
SDS-PAGE and transferred to a polyvinylidene difluoride membrane.
AceA was detected in membrane fractions (100,000 3 g pellets) using a
partially purified polyclonal antiserum against wild type AceA (see
“Experimental Procedures”).
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tional importance of the EX7E motif (residues Glu-510 and
Glu-518) of the human muscle glycogen synthase (HMGS) was
recently evaluated by replacement of either residue by Ala (28).
HMGS is a retaining processive glycosyltransferase that be-
longs to CaZY family 3. The results obtained are essentially the
same as those reported here, where mutant E510A of HMGS
(equivalent to AceA E287) is essentially inactive, while E518A
(corresponding to AceA E295) retains residual activity. It was
also found that both HMGS E510A and E518A mutant proteins
retained their ability to translocate and bind glycogen, strongly
suggesting that the EX7E motif is not critical for acceptor
substrate binding but rather forms the active site of the glyco-
gen synthase. Recent studies on the retaining processive gly-
cosyltransferase starch synthase II, which belongs to CaZY
family 5, again revealed that the replacement of the first res-
idue of the motif Glu-391 (equivalent to AceA Glu-287 and
HMGS Glu-510) by Gln inactivates the enzyme (29). The mu-
tagenic results of the second Glu of the EX7E motif, AceA
Glu-295 and HMGS 518, indicate that this residue plays an
important role in the transferase activity, and the threading
analysis as well as secondary structure comparison studies
with MurG and T4bGlcT suggest that this residue is involved
in binding the ribose moiety of the nucleotide sugar donor. It
has also been reported that a variant of the EX7E motif
(EX7(E,Y,H)) is present in members of CaZY family 5 (28). If
the role of the second Glu of the EX7E motif is indeed to bind a
hydroxyl group of ribose, it is conceivable that this function
could be undertaken by protic amino acids such as Tyr or His.
The secondary structure alignment based on the threading
studies with the T4bGlcT suggested that AceA Asp-109 is anal-
ogous to T4bGlcT Asp-100 and therefore might be a catalytic
amino acid. However, the AceA mutant D109A retained signif-
icant activity, especially in the in vivo assay, indicating that
this non-conserved residue may serve some role in the activity,
but is most likely not one of the residues directly involved in
catalyzing the transferase reaction. In the T4bGlcT structure,
Asp-100 contacts Arg-191 by interdomain salt bridges and also
binds the b-phosphate of UDP through a water molecule (22).
Therefore, by analogy, reduction in AceA activity upon muta-
tion of Asp-109 may reflect a disruption of the nucleotide sugar
binding pocket. Finally, functional roles for residues His-127
and Ser-162, mutation of which resulted in only a partial inac-
tivation of AceA, could not be proposed from the structural
comparisons with T4bGlcT and MurG. We note, however, that
AceA His-127 is located at a position equivalent to MurG His-
125 (25), which in turn is strictly conserved among all MurG
proteins cloned to date, and proposed to be located in the
acceptor binding site.
All members of CaZY family 4 possess a strictly conserved
Lys residue. In AceA this residue is Lys 211. The secondary
structure predictions place this residue in a loop early in the
COOH-terminal domain between a short b-sheet and an a-he-
lix. The UDP-binding contacts observed in the T4bGlcT-UDP
complex include Arg-191, which is found in an analogous struc-
tural position as that predicted for AceA Lys-211 (see Fig. 2).
The Arg-191 side chain makes a direct contact with the a-phos-
phate of UDP (21, 22). In the model of MurG bound to its
substrate UDP-GlcNAc, again, the binding of the nucleotide
sugar a-phosphate is attributed to a loop (G3 loop) (25) in the
analogous position as those containing AceA Lys-211 and
T4bGlcT Arg-191. These structural observations, taken to-
gether with the fact that replacement of AceA Lys-211 with Ala
results in a complete loss of activity, lead us to propose that
AceA Lys-211 binds one of the phosphate residues of the GDP-
Man donor. Interestingly, despite the fact that both MurG and
T4bGlcT have been reported to require a divalent cation to
function, no cation has been described in the crystal structures
(22, 25). In the group of glycosyltransferases described here, it
appears that nucleotide binding involves a direct protein inter-
action with a positively charged element of the protein. This is
in contrast to the “DXD”-containing glycosyltransferases (30),
in which the available structures show (24) or suggest (23) that
a Mn21 ion bind the nucleotide-sugar phosphate groups form-
ing a bridge with the conserved Asp residues in the binding
site.4 Our preliminary results suggest that AceA does not have
a strict functional requirement for Mn21 or Mg21, as this
enzyme is active in the absence of added divalent cation, and
retains .70% activity in the presence of 1 mM EDTA or EGTA.
Neither glycogen synthase nor starch synthase have require-
ment for a divalent cation either. It is possible that enzymes
such as MurG and T4bGlcT require a divalent cation for effec-
tive acceptor substrate binding rather than nucleotide sugar
binding, since both their substrates, lipid I and DNA, respec-
tively, also contain pyrophosphates groups. A crystal structure
of a retaining glycsoyltransferase belonging to CaZY family 4
as well as more sophisticated biochemical studies of AceA and
mutant proteins will begin to shed more light on the catalytic
mechanisms of this exciting group of glycosyltransferases.
Based on the very low (,3%) in vitro activity of recombinant
AceA D109A, H127A, or S162A, we expected a low production
of xanthan gum in the respective XcH strains. However, the
xanthan accumulated by these strain accounts for 21%, 39%,
and 18% of the quantities accumulated by XcH expressing
wild-type AceA. A similar phenomenon was observed by Gari-
not-Schneider et. al. (31) when expressing low active forms of
the glucosyltransferase ExoM in the Sinorhizobium meliloti
exoM mutant strain. These results suggest that the bottle neck
for exopolysaccharide production is not the assembly of the
repeat unit oligosaccharide, but possibly the supply of either
enzyme substrates (nucleotide-diphosphosugar or polyprenol),
or downstream steps (translocation or polymerization). For
example, it has been reported that introduction of a DNA
fragment-containing phosphomannose isomerase (first enzyme
in the pathway to GDP-Man) into X. campestris results in a
10–20% increase in xanthan production (32). Identification of
the hierarchy of bottlenecks in the biosynthetic pathway will be
important for future biotechnological applications such as po-
lysaccharide engineering.
In our earlier work, AceA expressed in E. coli was located in
the 100,000 3 g supernatant, despite the presence of a pre-
dicted transmembrane helix (3). During this work, in verifying
the correct expression of AceA in X. campestris, it was discov-
ered that AceA is found in the membrane fraction rather than
the soluble fraction. This finding suggests that AceA might be
retained at the membrane via interactions with other members
of the xanthan biosynthetic pathway as would be predicted if a
multi-enzyme biosynthetic complex existed. To determine
whether the membrane-retaining partner of AceA is part of the
xanthan biosynthetic pathway, we expressed AceA in X.
campestris strain Xc 1231 in which the entire gum region has
been deleted. Surprisingly, we found that AceA remained as-
sociated to the membrane fraction, suggesting that some other
feature is necessary for membrane retention in X. campestris.
Since it was difficult to obtain stable expression of AceA in the
gum deletion strain, it is possible that this protein is less stable
in the absence of the other Gum proteins. As AceA is not native
to X. campestris, nor does X. campestris possess the acetan
biosynthetic mechanism that AceA would normally be associ-
ated with, these results neither contradict nor confirm the
4 An Mn21 ion was also found in the structure of human glucurono-
syltransferase 1 (33).
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existence of a multi-enzyme complex being involved in xanthan
biosynthesis.
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